blog.pawealth.in/2023/06/17/syngene-international-ltd-bridging-the-gap-between-science-and-solutions/
1 Users
0 Comments
8 Highlights
1 Notes
Tags
Top Highlights
Syngene International beneficiary of the shift from Chemical drugs to biological drugs.
Syngene is one of India’s leading CRAMS organisations
Company has grown its revenue at 17.54% in past 5 years, while PAT grew at a CAGR of 8.73%
Shift from chemical drugs to biological drugs
Out of top 10 selling drugs in the world 8 are biologics.
Every year, around 2/3rd of the new business comes from existing clients and the rest from new clients.
Hyderabad which expanded further in Q4 FY23 ¤tly accommodates ~900 scientists.
during the year, the campus in Hyderabad added 400 scientists
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.